Wednesday, February 10, 2010, 2:24pm SGT - The Singapore stock market closes in 2 hours and 36 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

Elan Corp. plc (ELN)

At 5:01AM SGT: 7.07 USD  Up 0.10 (1.43%)  
 MORE ON ELN 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 ELAN CP PLC ADR (NYSE:ELN) Delayed quote dataEdit
After Hours: 7.14 Up 0.07 (0.99%) as of 8:59am SGT on 02/10/10
Last Trade:7.07 USD
Trade Time:5:01AM SGT
Change:Up 0.10 (1.43%)
Prev Close:6.97
Open:7.10
Bid:N/A
Ask:N/A
1y Target Est:8.39
Day's Range:6.95 - 7.15
52wk Range:4.61 - 8.59
Volume:2,730,161
Avg Vol (3m):2,737,700
Market Cap:3.48B
P/E (ttm):66.70
EPS (ttm):0.11
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add ELN to Portfolio   Download Data

 HEADLINES 
[audio] [audio] Elan Corporation, plc Earnings Conference Call (live tomorrow at 8:30 am ET)
•[$$] Earnings watch
at The Wall Street Journal Online (Wed 8:35am)
•Biogen Beats & Guides Higher
Zacks.com (Wed 5:18am)
•Biogen reports higher profit, raises forecast
at MarketWatch (Wed 2:10am)
•UPDATE - Biogen 4th-qtr profit up, outlook tops estimates
at Reuters (Wed 12:32am)
•[$$] Tysabri Boosts Biogen Earnings
at The Wall Street Journal Online (Tue 11:38pm)
•Biogen 4Q profit grows 48 percent on Tysabri sales
AP (Tue 10:22pm)
•UPDATE - US warns of risk rise with more Tysabri infusions
at Reuters (Sat, Feb 6)
•FDA warns of brain risks with frequent Tysabri use
AP (Sat, Feb 6)
•7 Reasons to Worry About Next Week
at Motley Fool (Fri, Feb 5)
•Infosys Technologies and Elan Pharmaceuticals Apply Co-creation Model to Transform Discovery Research
PR Newswire (Fri, Feb 5)
•Ride the Space Elevator to Riches!
at Motley Fool (Thu, Feb 4)
More Headlines for ELN...
 ANALYST 
EPS Est (next year) (Dec-09) :-0.51
EPS Est (in 2 years) (Dec-10) :-0.21
Avg Rec (current)*:3.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Elan Corporation, plc operates as a neuroscience-based biotechnology company primarily in Ireland and the United States. It operates in two segments, Biopharmaceuticals and Elan Drug Technologies (EDT).

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices